ACTION Registry®–GWTG™ is a national, risk-adjusted, outcomes-based quality improvement program that helps participating facilities measure and improve care for high-risk ACS patients with STEMI and NSTEMI. The result of the collaboration between the two leading national coronary artery disease registries, the NCDR® ACTION Registry® and the American Heart Association (AHA) Get With The GuidelinesSM-CAD Registry, ACTION Registry–GWTG will be the largest, most comprehensive national cardiovascular patient database ever developed by the medical profession.
Combining the strengths of the two programs, ACTION Registry–GWTG will collect a comprehensive set of data elements that provide healthcare professionals and their facilities with the information they need to monitor and improve adherence to the most current, science-based ACC/AHA treatment guidelines. Participation will greatly facilitate quality improvement efforts, optimize clinical care, and improve clinical outcomes for acute coronary syndrome patients.
Visit How To Join to request additional information or to download an enrollment package. Or, visit the ACTION website for more information.
ACEP 2009 EMCREG Symposium: Cardiovascular and Neurovascular Emergencies
Miss us at ACEP 2009? Complimentary Webcast Available On-line!
View all the Presentations On-line! Please feel to view the webcasts of each presentation. These webcasts are complimentary and includes CME for those who register before viewing.
ST-segment Elevation Myocardial Infarction (STEMI): Optimal Antiplatelet and Antithrombotic Therapy in the Emergency Department
James W. Hoekstra, MD Novel Antiplatelet and Antithrombin Therapy for Acute Coronary Syndromes: STEMI and NSTEMI Optimal Antiplatelet and Antithrombotic Therapy in the
Emergency Department
W. Brian Gibler, MD American Heart Association Mission Lifeline: Developing a STEMI Regional Care System
Deborah B. Diercks, MD Ideal Management of Acute Heart Failure Syndromes in the Emergency Department
Judd E. Hollander, MD Cadvanced Stroke Care: Avoiding Medical-Legal Disasters in the Emergency Department
Arthur M. Pancioli, MD
It is our hope that this material will provide emergency physicians with information necessary to improve and facilitate care for this unique patient
population.
ACEP 2008 EMCREG Symposia: Cardiovascular and Neurovascular Emergencies
Miss us at ACEP 2008? Complimentary Webcasts Available On-line!
View all the Presentations On-line! Please feel to view the webcasts of each presentation. These webcasts are free of charge and includes CME for those who register before viewing.
The New 2007 ACC/AHA Guidelines: Optimum Antiplatelet and Antithrombin Management in NSTE-ACS
Charles V. Pollack, MD Focused Update on the 2007 STEMI ACC/AHA STEMI Guidelines: Implications for ED Practice
James E. Hoekstra, MD Evolving Therapies for ACS: Moving Forward with Novel Antiplatelet and Anti-thrombin Treatment
Deborah B. Diercks, MD Advances in Point-of-Care Testing for Chest Pain Centers: Impact on ACS and Heart Failure Diagnosis
J. Lee Garvey, MD Case Studies: Rapid Diagnosis and Optimal Therapy for ACS and Heart Failure
Charles V. Pollack, MD; James W. Hoekstra, MD; Deborah B. Diercks, MD; and J. Lee Garvey, MD Evaluation and Treatment of Hypertension in the ED
W. Brian Gibler, MD Advances in the Diagnosis and Treatment of Stroke
Arthur M. Pancioli, MD Acute Heart Failure Syndromes – Stratifying Patients According to Risk
J. Douglas Kirk, MD Evolving Therapy for Heart Failure: Novel Approaches to Management in the ED
Sean P. Collins, MD State of the Art Early Detection and Treatment of DVT and Pulmonary Embolism
Charles B. Carins, MD
It is our hope that this material will provide emergency physicians with information necessary to improve and facilitate care for this unique patient
population.
ACEP 2007 EMCREG Symposia: Cardiovascular, Neurovascular and Infectious Emergencies
Miss us at ACEP 2007?
View all the Presentations On-line! Please feel to view the webcasts of each presentation. These webcasts are free of charge and includes CME for those who register before viewing.
These symposia represented a unique opportunity to hear and interact with experts in emergency cardiovascular, neurovascular and infectious care and to gain up-to-date knowledge on the full spectrum of decision-making and care for patients with stroke and TIA, acute heart failure, hypertensive emergencies, acute coronary syndromes (ACS) including non-ST-segment elevation MI (NSTEMI) and ST-segment elevation myocardial infarction (STEMI), severe bacterial infections, and venous thromboembolism (DVT and PE).
It is our hope that this material will provide emergency physicians with information necessary to improve and facilitate care for this unique patient
population.
The following CME-certified webcasts are provided as an educational service by CMEducation Resources, LLC, an award-winning organization devoted to providing national expert-based, scientifically rigorous programming focused on cardiovascular disease for the emergency medicine and critical care specialist.
Program Overview:
An international faculty provides a detailed review of the latest advances in STEMI management and high-risk ACS, including an analysis of the latest clinical guidelines and their impact on patient care.
An international faculty provides a detailed review of the latest advances in STEMI management and high-risk ACS, including an analysis of the latest clinical guidelines and their impact on patient care.
Dr. Matthew Weir and his distinguished colleagues discuss the evolving developments in the role of beta-blockers across the spectrum of care for heart disease patients, with a with a focus on mechanism of action, comparative features, and treatment guidelines.
Part one of a three-part series, this CME Clinical Excellence DVT-WRAP focuses on DVT risk assessment and intervention upon hospital admission. Samuel Z. Goldhaber, MD, of Harvard Medical School, discusses real-world applications of clinical guidelines.
Part two of a three-part series, this CME Clinical Excellence DVT-WRAP focuses on dynamic DVT risk assessment during hospital admission, and the “failure to prevent” syndrome in hospitals. Samuel Z. Goldhaber, MD, of Harvard Medical School, discusses evolving and unexpected triggers for VTE prophylaxis in the hospital setting.
Dr. Sunil Rao provides a comprehensive overview of the use of antiplatelet therapy in acute coronary syndrome and cardiovascular surgery, with a particular focus on issues of timing, safety, and bleeding risk, and also reviews clinical guidelines for the use of thienopyridines.
A nationally-known faculty presents the latest evidence-based best practice strategies that interventional cardiologists and their emergency medicine colleagues can implement for patients with STEMI and high risk ACS.
An international faculty of interventional cardiology experts discuss the recent European Society of Cardiology guidelines for STEMI in light of recent landmark clinical trials focusing on mortality reduction in a roundtable question-and-answer session that includes answers in English, French, Italian and German.
Charles V. Pollack, MD, FACEP and his distinguished colleagues illuminate the emerging threats, clinical challenge, and new therapeutic paradigms for emergency medicine specialists managing patients who present with, or undergo, acute, severe, serious, precipitous, and/or life-threatening elevations in systemic blood pressure.
This program, Landmark Advances in Cardiovascular Anesthesiology – The Science and Medicine of Acute Pressure Syndromes, is intended to measurably enhance the quality of care you provide for patients at risk for severe and/or life-threatening elevations in blood pressure.
This CME Clinical Excellence ACS-WRAP focuses on pharmacoinvasive management of acute coronary syndromes, with an emphasis on incorporating different practice strategies for both ACS and STEMI. Harold Dauerman, MD, FACC, discusses the real-world integration of these protocols, particularly in regards to transfer patients, at the University of Vermont Medical Center.
In this multimedia STEMI-WRAP, Gregg W. Stone, MD, FACC discusses the landmark HORIZONS-AMI Trial and its implications for mortality and the management of patients in the emergency department and the catheterization suite with high risk ACS
Researchers report that a novel method for using natriuretic-peptide testing can optimize postdischarge therapy after acute heart-failure decompensation, reduce hospitalization, and improve outcomes.
Results of the PLATO trial show that the reversible P2Y12 inhibitor ticagrelor reduces death and cardiovascular events compared with clopidogrel therapy in ACS patients.
Denmark researchers report in Lancet that relative risk for hospitalization for bleeding increased with all drug combinations and with each additional drug used.
Researchers report that the to reperfusion, beginning with symptom onset time, determines the extent of reversible myocardial injury in STEMI patients undergoing PCI.
